Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Khatamzas, E; Mellinghoff, SC; Thelen, M; Schlößer, HA; Kunz, WG; Buerkle, C; Dichtl, K; Ormanns, S; von, Bergwelt-Baildon, M.
Nivolumab induces long-term remission in a patient with fusariosis.
Eur J Cancer. 2022; 173:91-94 Doi: 10.1016/j.ejca.2022.06.035
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz

Dichtl Karl

Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Find related publications in this database (using NLM MeSH Indexing)

Fusariosis - administration & dosage

Humans - administration & dosage

Immunocompromised Host - administration & dosage

Nivolumab - therapeutic use

Remission Induction - administration & dosage

© Med Uni Graz • Imprint